¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hepatitis b surface antigens"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • surface refrigeration anesthesia
    Ç¥¸é³Ãµ¿¸¶Ãë
  • surface tension
    Ç¥¸éÀå·Â
  • surface tension depressant
    Ç¥¸éÀå·ÂÀúÇÏÁ¦
  • surface thermometer
    Ç¥¸é¿Âµµ°è
  • surface water
    ÁöÇ¥¼ö
  • surface-active disinfectant
    Ç¥¸éȰ¼º¼Òµ¶Á¦
  • ventral surface
    ¹èÂʸé, ¾Õ¸é, º¹Ãø¸é
  • vestibular surface
    ¾È¶ã¸é, ÀüÁ¤¸é
  • visceral surface
    ³»Àå¸é
  • variant surface glycoprotein
    »óÀÌÇ¥¸é´ç´Ü¹éÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • surface lubricant
    Ç¥¸éÀ±È°Á¦
  • malleolar articular surface
    º¹»ç°üÀý¸é, Á·±Ù°ú°üÀý¸é
  • surface mold
    Ç¥ÇÇÆ², Ç¥ÇÇÁÖÇü
  • potential surface
    ÀüÀ§¸é
  • proximate surface
    ÀÎÁ¢¸é
  • quadratic surface
    ÀÌÂ÷°î¸é
  • surface
    Ç¥¸é, ¸é
  • sacropelvic surface
    ¾ûÄ¡°ñ¹Ý¸é, õ°ñ°ñ¹Ý¸é
  • skin surface temperature
    ÇǺÎÇ¥¸é¿Âµµ
  • superolateral surface
    À§°¡Âʸé
  • surface tension
    Ç¥¸éÀå·Â
  • surface thermometer
    Ç¥¸é¿Âµµ°è
  • surface water
    ÁöÇ¥¼ö
  • ventral surface
    ¹èÂʸé, ¾Õ¸é
  • vestibular surface
    ¾È¶ã¸é
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • antigen, hepatitis B core
    BÇü °£¿°¹ÙÀÌ·¯½º ÇÙ½ÉÇ׿ø
  • granulomatous hepatitis
    À°¾ÆÁ¾¼º °£¿°.
  • gummatous hepatitis
    °í¹«Á¾¼º °£¿°.
  • hemorrhagic hepatitis
    ÃâÇ÷(¼º) °£¿°.
  • hepatitis
    °£¿°(ÊÜæú).
  • hepatitis A virus(HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis A virus (HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis B core antigen (HBc Ag)
    BÇü °£¿°¹ÙÀÌ·¯½º ÇÙ½ÉÇ׿ø
  • hepatitis B virus(HBV)
    BÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis C virus(HCV)
    CÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis D coinfection
    D Çü °£¿°µ¿½Ã°¨¿°
  • hepatitis D virus(HDV)
    DÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis E virus(HEV)
    EÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis F virus(HFV)
    FÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis G virus(HGV)
    GÇü °£¿°¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • hepatitis,type b
    B Çü
  • infantile hepatitis
    ¿µ¾Æ°£¿°.
  • infectious hepatitis
    Àü¿°¼º °£¿°(îîæøàõÊÜæú).
  • infectious hepatitis
    Àü¿°¼º °£¿°, AÇü°£¿°
  • infectious hepatitis virus
    Àü¿°¼º °£¿° ¹ÙÀÌ·¯½º.
  • lupoid hepatitis
    ·çÆ÷À̵尣¿°, ³¶Ã¢¾ç°£¿°(¡­ÊÜæú).
  • lupoid hepatitis
    ·çÆ÷À̵尣¿°, ³¶Ã¢¾ç°£¿°(³¶Ã¢¾çÊÜæú)
  • lupus hepatitis
    ·çǪ½º°£¿°
  • milkborne infectious hepatitis
    ¿ìÀ¯Àü¿°¼º°£¿°(ËíËôËøËçËÛ˧Ëç).
  • milkborne infectious hepatitis
    ¿ìÀ¯Àü¿°¼º °£¿°(éÚêáîîæøàõÊÜæú).
  • mouse hepatitis
    ¸¶¿ì½º°£¿°(¡­ÊÜæú).
  • murine hepatitis virus
    ¸¶¿ì½º °£¿° ¹ÙÀÌ·¯½º
  • neonatal hepatitis
    ½Å»ý¾Æ°£¿°(~ÊÜæú).
  • non-A, non-B, hepatitis=NANBH
    ºñAºñB °£¿°
  • non-A, non-B, non-C hepatitis
    ºñA ºñB ºñC °£¿°
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Superior articular surface
    À§°üÀýµ¹±â
    [¿¾ ¿ë¾î] »ó°üÀýµ¹±â
  • Superior articular surface
    À§°üÀý¸é
    [¿¾ ¿ë¾î] »ó°üÀý¸é
  • Gastric surface
    À§¸é
    [¿¾ ¿ë¾î] À§¸é
  • Superior surface
    À§¸é
    [¿¾ ¿ë¾î] »ó¸é
  • Maxillary surface
    À§Åθé
    [¿¾ ¿ë¾î] »ó¾Ç¸é
  • Dorsal surface
    À½°æµî
    [¿¾ ¿ë¾î] À½°æ¹è
  • Articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
    [¿¾ ¿ë¾î] ÀÔ¹æ°ñ°üÀý¸é
  • Labial surface
    ÀÔ¼ú¸é
    [¿¾ ¿ë¾î] ±¸¼ø¸é
  • Palatine surface
    ÀÔõÀå¸é
    [¿¾ ¿ë¾î] ±¸°³¸é
  • Approximal surface
    Á¢Ã˸é
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Articular surface for fibula
    Á¾¾Æ¸®°üÀý¸é
    [¿¾ ¿ë¾î] ºñ°ñ°üÀý¸é
  • Articular surface of fibular head
    Á¾¾Æ¸®»À¸Ó¸®°üÀý¸é
    [¿¾ ¿ë¾î] ºñ°ñµÎ°üÀý¸é
  • Colic surface
    ÁÖ¸§Ã¢ÀÚ¸é
    [¿¾ ¿ë¾î] °áÀå¸é
  • Middle articular surface for talus
    Áß°£¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] Á߰Űñ°üÀý¸é
  • Middle calcaneal articular surface
    Áß°£¹ß²ÞÄ¡°üÀý¸é
    [¿¾ ¿ë¾î] ÁßÁ¾°ñ°üÀý¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
AMLSGA acute myeloblastic leukemia surface glycoprotein antigen
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
BSA benzenesulfonic acid; Biofeedback Society of America; bismuth-sulfite agar; bis-trimethylsilyl-aceta...
BSB body surface burned
Cs case; cell surface; cesium; cyclosporine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
ISA Internal surface area
ISRP Internal surface reversed-phase
ICSA Islet cell surface antibodies
MSP major surface protein
MSP-1 merozite surface protein-1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • surface temperature
    Ç¥¸é ¿Âµµ
  • surface zone
    Ç¥Ãþ, Ç¥Ãþ´ë
  • symphysial surface
    Ä¡°ñ °áÇÕ¸é
  • temporal surface of frontal bone
    ÀüµÎ°ñ ÃøµÎ¸é
    µ¿ÀǾî=facies tem
  • temporal surface of squamous part
    ºñ´Ã ºÎºÐ ÃøµÎ¸é, Àμ³ÀÇ ÃøµÎ¸é
    µ¿ÀǾî=facies tem
  • temporal surface of zygomatic bone
    ±Ç°ñ ÃøµÎ¸é, °ñ ÃøµÎ¸é
    µ¿ÀǾî=facies tem
  • ventral surface
    º¹¸é
  • verrucous surface
    ¿ìÃé»ó ¸é
  • virus-specific surface antigen
    ¹ÙÀÌ·¯½º ƯÀ̼º Ç¥¸é Ç׿ø ¹ÙÀÌ·¯½º
  • wartlike surface lesion
    »ç¸¶±Í°°Àº Ç¥¸é º´¼Ò
  • wettable surface
    ½ÀÀ± Ç¥¸é
  • whitish keratotic surface
    ¹é»ö °¢È­¸é, ¹é»öÀÇ °¢È­¸é
  • working surface
    ÀÛ¾÷ ¸é
    ÀÛ¾÷ÇÏ´Â ¸éÀ» ÀǹÌÇÏ¸ç °ð Ä¡¾ÆÀÇ ±³ÇÕ¸éÀ» ¸»ÇÑ´Ù. Á¤È®È÷ ¸»Çϸé ÇÏ¾Ç ±¸Ä¡ÀÇ ÇùÃø ±³µÎ°¡ »ó¾Ç ±¸Ä¡ÀÇ Áß¾Ó ÇÔ¸ôºÎ¿¡ Á¢Ã˵Ǵ ¸éÀ» ¸»Çϸç ÀüÄ¡ºÎÀÇ °æ¿ì¿¡´Â ÇÏ¾Ç °ßÄ¡¿Í ÀýÄ¡ÀÇ Àý´Ü À¶¼±ÀÌ »ó¾Ç °ßÄ¡¿Í ÀýÄ¡ÀÇ ¼³Ãø¿¡¼­ Á¢ÃËÇÏ¿© Çü¼ºÇÏ´Â ¸éÀ» ¸»ÇÑ´Ù.
  • zero surface
    Á¦·Î ¸é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
HLA-a antigens <immunology> Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. at least 20 antigens have been identified which are encoded by the a locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts.
(12 Dec 1998)
HLA antigens <immunology> A complex family of genetically inherited proteins which are found on the surface of cells throughout the body.
They determine the match between patient and potential donor in bone marrow transplantation. These factors are inherited from the mother and father and so the chance of having the same HLA antigens between siblings is 1 in 4.
See: human lymphocyte antigens.
(20 Jun 2000)
HLA-b antigens <immunology> Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus b of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-b27, -b7, -b8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic t lymphocytes.
(12 Dec 1998)
HLA-c antigens <immunology> Class I human histocompatibility (HLA) antigens encoded by a small cluster of structural genes at the c locus on chromosome 6. They have significantly lower immunogenicity than the HLA-a and -b determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations (e.g., spondylarthritis, psoriasis, multiple myeloma).
(12 Dec 1998)
HLA-d antigens <immunology> Human immune-response or class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-d locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -dr, -dq and -dp designations, of which HLA-dr is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune aetiology.
(12 Dec 1998)
HLA-dp antigens <immunology> A group of the d-related HLA antigens (human) found to differ from the dr antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.
(12 Dec 1998)
HLA-dq antigens <immunology> A group of the d-related HLA antigens found to differ from the dr antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.
(12 Dec 1998)
HLA-dr antigens <immunology> A group of d-related human leukocyte antigens that are polymorphic glycoproteins found on lymphoid cells. They consist of alpha and beta chains and their inheritance differs from that of the dq and dp antigens; their presence seems to be associated with certain skin diseases like pemphigus vulgaris, dermatitis herpetiformis, and type I diabetes.
(12 Dec 1998)
HTLV-blv antigens Antigens associated with the HTLV-blv viruses. Htlv-I antigens and HTLV-II antigens belong to this group.
(12 Dec 1998)
HTLV-I antigens Antigens associated with the HTLV-I virus.
(12 Dec 1998)
HTLV-II antigens Antigens associated with the HTLV-II virus.
(12 Dec 1998)
Hu antigens he antigens
human leukaemia-associated antigens Antigen's on the surface of leukaemic cells which seem not to be present on the surfaces of the same type of normal cells; the myeloblast antigen of acute myelogenous leukaemia found in chronic myelogenous leukaemia is thought to be associated with a "blastic" transformation.
(05 Mar 2000)
human leukocyte-associated antigens Proteins on the outer part of body cells that help fight illness. These proteins vary from person to person. Scientists think that people with certain types of HLA antigens are more likely to develop insulin-dependent diabetes.The HLA antigens are also responsible for histocompatibility reactions.
(09 Oct 1997)
specific antigens Antigen's that characterise a single genus of microorganisms.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á